Crossmark

Response to Crudele et al. Commentary on Mayock et al. “In Vitro Drug Release after Crushing: Evaluation of Xtampza® ER and Other ER Opioid Formulations”

Crossref DOI link: https://doi.org/10.1007/s40261-018-0664-y

Published Online: 2018-06-12

Published Print: 2018-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fleming, Alison B.

Mayock, Stephen P.

Saim, Said
License Information

Text and Data Mining valid from 2018-06-12
More Information

Article History

First Online: 12 June 2018

Compliance with ethical standards

:

: No source of funding was used to prepare this response.

: All authors are employees of Collegium Pharmaceutical, Inc.

Document is current

Any future updates will be listed below